Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Equashield, founded in 2009 and headquartered in Port Washington, New York, is a leading medical device company specializing in Closed System Transfer Devices (CSTDs). We focus on developing and providing innovative solutions for the safe handling of hazardous drugs in healthcare settings. Our product range includes closed syringes, adapters, connectors, and tubing sets designed to protect healthcare workers from exposure to potentially harmful substances.
The company has shown significant growth since its inception, attracting substantial investment. In October 2022, Equashield secured a $300 million private equity investment from Nordic Capital, valuing the company at $1.3 billion. This funding round demonstrates investor confidence in Equashield's business model and growth potential within the medical devices and equipment industry.
While there is currently no official information available regarding Equashield's IPO prospects, the company's recent funding success and strong market position in the healthcare sector may generate interest among potential investors. However, it's important to note that any discussions about a possible Equashield IPO remain speculative at this time.
Factors that could influence Equashield's decision to go public in the future might include market conditions, the company's financial performance, and strategic growth plans. As a leader in the medical device industry, Equashield's focus on safety and innovation in healthcare could be attractive to investors looking to diversify their portfolios with healthcare stocks.
Investors interested in Equashield should keep an eye on official company announcements and industry news for any updates regarding potential IPO plans. As always, it's crucial to conduct thorough research and consider various factors before making investment decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Equashield's IPO prospects remain uncertain, investors interested in the medical technology sector don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential industry leaders like Equashield, with lower minimum investments than traditional private equity opportunities. This allows you to diversify your portfolio and potentially benefit from the growth of innovative companies in the healthcare and medical device space.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
